BAE; In Hwan

Patent Applications and Registrations

Patent applications and USPTO patent grants for BAE; In Hwan.The latest application filed is for "pharmaceutical composition comprising flt3 inhibitor and hypomethylating agent for treating acute myeloid leukemia".

Company Profile

14.11.13

BAE; In Hwan - Hwaseong-si KR
Bae; In Hwan - Changwon-si KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Composition Comprising Flt3 Inhibitor And Hypomethylating Agent For Treating Acute Myeloid Leukemia App 20220110913 - BAE; In Hwan ; et al.	2022-04-14
Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same Grant 11,292,786 - Bae , et al. April 5, 2	2022-04-05
Imidazopyridine Derivative Compounds And Use Of Same App 20220098205 - BAE; In Hwan ; et al.	2022-03-31
Pyrazole derivative compound and use thereof Grant 11,254,676 - Bae , et al. February 22, 2	2022-02-22
Pyrazole Derivative Compound And Use Thereof App 20210009591 - BAE; In Hwan ; et al.	2021-01-14
Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same Grant 10,870,639 - Bae , et al. December 22, 2	2020-12-22
Thieno[3,2-d]pyrimidine Derivative Compound Having Inhibitory Activity For Protein Kinase App 20200308188 - BAE; In Hwan ; et al.	2020-10-01
Pyrimidine Compounds And Pharmaceutical Compositions For Preventing Or Treating Cancers Including The Same App 20200255410 - Kind Code	2020-08-13
Pyrimidine Compounds And Pharmaceutical Compositions For Preventing Or Treating Cancers Including The Same App 20200031806 - BAE; In Hwan ; et al.	2020-01-30
Pyrimidine compound and pharmaceutical use thereof Grant 10,519,141 - Ham , et al. Dec	2019-12-31
Compressor control system and method Grant 10,487,841 - Bae , et al. Nov	2019-11-26
Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases Grant RE47,451 - Bae , et al.	2019-06-25
Pyrimidine compound and pharmaceutical use thereof Grant 10,280,154 - Ham , et al.	2019-05-07
Pyrimidine Compound And Pharmaceutical Use Thereof App 20190127353 - HAM; Young Jin ; et al.	2019-05-02
Pyrimidine Compound And Pharmaceutical Use Thereof App 20190031643 - HAM; Young Jin ; et al.	2019-01-31
Compressor Control System And Method App 20180010611 - BAE; In Hwan ; et al.	2018-01-11
Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinase Grant 9,388,165 - Bae , et al. July 12, 2	2016-07-12
Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases Grant 9,156,852 - Bae , et al. October 13, 2	2015-10-13
Isoquinoline-5-carboxamide Derivative Having Inhibitory Activity For Protein Kinase App 20150191450 - Bae; In Hwan ; et al.	2015-07-09
Thieno[3,2-d]pyrimidine Derivatives Having Inhibitory Activity For Protein Kinases App 20140371219 - Bae; In Hwan ; et al.	2014-12-18
Quinoline or quinazoline derivatives with apoptosis inducing activity on cells Grant 8,835,458 - Bae , et al. September 16, 2	2014-09-16
Quinoline Or Quinazoline Derivatives With Apoptosis Inducing Activity On Cells App 20130165386 - Bae; In Hwan ; et al.	2013-06-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.